Theriva Biologics, Inc. (TOVX) AMEX
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.55M |
| Enterprise Value | -7.87M |
| P/E Ratio | -0.09 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 27.98 |
| Price/Book Ratio | 0.63 |
| Enterprise/Revenue | -7.81 |
| Enterprise/EBITDA | 0.11 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -71.53 |
| Operating Margin | -72.45 |
AD
Management Effectiveness
| Return On Assets | -0.56 |
| Return On Equity | -1.78 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0.01 |
| Gross Profit | -108,000 |
| EBITDA | -23.63M |
| Net Income | -25.25M |
| Diluted EPS | -2.08 |
Balance Sheet
| Total Cash | 14.43M |
| Total Cash/Share | 0.35 |
| Total Debt | 3.69M |
| Total Debt/Equity | 0.24 |
| Current Ratio | 1.63 |
| Book Value Per Share | 0.37 |
Price History
| 52-Week Change | -52.68 |
| 52-Week High | 0.86 |
| 52-Week Low | 0.16 |
| Moving Average 50 Days | 0.29 |
| Moving Average 200 Days | 0.27 |
Statistics
| Average Volume | 21.21M |
| Shares Outstanding | 35.69M |
| % Held by Institutions | 16.19 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | August 26, 2024 |
AD
